Safety, quality & education

Effects of a multilevel intervention of resistance training with or without beta-hydroxy-beta-methylbutyrate in medical ICU patients during entire hospitalisation: a four-arm multicentre randomised controlled trial

Crit CarePublished Randomised controlled trial

Authors' conclusion

Resistance training with or without beta-hydroxy-beta-methylbutyrate during the entire hospitalisation intervention improves physical function and muscle strength in medical ICU patients, but muscle mass, quality of life, and 60-day mortality were unaffected.

Study context

Population
Adult medical ICU patients with internal medical diagnoses
Participants
112 patients
Comparison
Resistance training, HMB, or combination vs standard care, from ICU to ward until discharge
Primary endpoint
6MWD and SPPB
Follow-up
Discharge
Methodological detailsmulticentre, four-arm, single-blind
  • Multicentre
  • Four-arm
  • Single-blind

Primary result

As reported in the abstract

SPPB and 6MWD
Resistance training
Short physical performance battery (SPPB) increase 3.848 points; P < 0.01
Combination
SPPB increase 2.832 points; P < 0.01
Resistance training
6MWD improvement 99.768 m; P < 0.01
Combination
6MWD improvement 88.577 m; P < 0.01

Secondary outcomes

Muscle strength (MRC, grip strength) at ICU and hospital discharge

Significant improvements in the resistance training and combination groups
P < 0.05

60-day mortality, intensive care unit-acquired weakness (ICU-AW) prevalence, muscle mass, quality of life, other functional aspects

No significant differences between treatment groups and usual care

Original publication

Effects of a multilevel intervention of resistance training with or without beta-hydroxy-beta-methylbutyrate in medical ICU patients during entire hospitalisation: a four-arm multicentre randomised controlled trial. Crit Care. Published 15 December 2023. doi:10.1186/s13054-023-04698-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.